1,251
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study

, ORCID Icon, , , , & show all
Article: 2200867 | Received 20 Aug 2023, Accepted 04 Mar 2023, Published online: 19 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.